Utilisation of quantitative parameters to assess hypothalamic damage therefore presents an important avenue in need of exploration when investigating the oxytocin system and neurobehavioural and metabolic outcomes, in patients with craniopharyngioma. Here, OXT is linked to craniopharyngioma.